Structure

InChI Key IKGXIBQEEMLURG-NVPNHPEKSA-N
Smiles C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(-c4ccc(O)c(O)c4)oc4cc(O)cc(O)c4c3=O)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O
InChI
InChI=1S/C27H30O16/c1-8-17(32)20(35)22(37)26(40-8)39-7-15-18(33)21(36)23(38)27(42-15)43-25-19(34)16-13(31)5-10(28)6-14(16)41-24(25)9-2-3-11(29)12(30)4-9/h2-6,8,15,17-18,20-23,26-33,35-38H,7H2,1H3/t8-,15+,17-,18+,20+,21-,22+,23+,26+,27-/m0/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C27H30O16
Molecular Weight 610.52
AlogP -1.69
Hydrogen Bond Acceptor 16.0
Hydrogen Bond Donor 10.0
Number of Rotational Bond 6.0
Polar Surface Area 269.43
Molecular species ACID
Aromatic Rings 3.0
Heavy Atoms 43.0
Assay Description Organism Bioactivity Reference
Inhibition of diphenolase activity of mushroom tyrosinase at 0.055 mM Agaricus bisporus 12.65 %
Inhibition of guinea pig classical complement system assessed as hemolysis of sensitized sheep erythrocytes at 1000 uM Cavia porcellus 54.4 %
Inhibition of human plasma alternative complement system assessed as hemolysis of non-sensitized rabbit erythrocytes at 1000 uM Homo sapiens 18.0 %
Toxicity in Salmonella Typhimurium T98 at 600 ug/plate after 72 hrs by Ames assay in presence of Ames S-9 fraction Salmonella enterica subsp. enterica serovar Typhimurium 20.0 %
Toxicity in Salmonella Typhimurium T98 at 300 ug/plate after 72 hrs by Ames assay in presence of Ames S-9 fraction Salmonella enterica subsp. enterica serovar Typhimurium 20.0 %
Antimutagenic activity in Salmonella Typhimurium T98 assessed as inhibition of 2-aminoanthracene-induced mutation at 600 ug/plate after 72 hrs in presence of Ames S-9 fraction Salmonella enterica subsp. enterica serovar Typhimurium 0.0 %
Inhibition of COX2 at 100 uM by scintillation proximity assay None 30.0 %
Inhibition of Saccharomyces cerevisiae fatty acid synthase Saccharomyces cerevisiae 50.0 ug.mL-1
Antifungal activity against Candida albicans ATCC 90028 Candida albicans 50.0 ug.mL-1
Antifungal activity against Cryptococcus neoformans ATCC 90113 Cryptococcus neoformans 30.0 ug.mL-1
Antiprotozoal activity against Entamoeba histolytica HM-1:IMSS trophozoites after 48 hrs by MTT/PMS assay Entamoeba histolytica HM-1:IMSS 119.7 ug.mL-1
Antiprotozoal activity against Giardia lamblia IMSS:0989:1 after 48 hrs by MTT/PMS assay Giardia intestinalis 178.7 ug.mL-1
Inhibition of TPA-induced EBV-early antigen activation in human Raji cells relative to TPA Human herpesvirus 4 578.0 molar ratio
Antioxidant activity assessed as DPPH radical scavenging activity after 20 mins by UV-visible spectrophotometry None 4.8 ug
Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 30 uM after 72 hrs Mus musculus 5.2 %
Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 10 uM after 72 hrs Mus musculus 4.3 %
Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 3 uM after 72 hrs Mus musculus 3.1 %
Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 1 uM after 72 hrs Mus musculus 4.5 %
Toxicity in mouse B16-4A5 cells assessed as inhibition of cell proliferation at 30 uM in presence of 1 mM theophylline after 72 hrs by WST8 dye reduction assay Mus musculus 8.8 %
Inhibition of Influenza A PR/8/34 H1N1 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay Influenza A virus (A/Puerto Rico/8/1934(H1N1)) 31.14 ug.mL-1
Antioxidant activity assessed as DPPH free radical scavenging activity None 15.5 ug
Inhibition of bovine kidney LMW-PTPase at 400 uM using pNPP substrate Bos taurus 14.0 %
Inhibition of electric eel AChE at 2 mg/ml by Ellman's method Electrophorus electricus -0.25 %
Inhibition of horse BChE at 2 mg/ml by Ellman's method Equus caballus 4.32 %
Antioxidant activity assessed as inhibition of xanthine-xanthine oxidase generated superoxide anion radical production at 200 ug/ml after 30 min by NBT reduction assay None 35.0 %
Antioxidant activity assessed as inhibition of xanthine-xanthine oxidase generated superoxide anion radical production at 100 ug/ml after 30 min by NBT reduction assay None 18.0 %
Antifungal activity against Verticillium dahliae assessed as inhibition of mycelial radial growth measured after 350 hr Verticillium dahliae 80.0 ug.mL-1
Antioxidant activity assessed as ABTS radical scavenging activity None 4.65 ug.mL-1
Antioxidant activity assessed as DPPH radical scavenging activity after 30 min None 1.83 ug.mL-1
Antiamoebic activity against Entamoeba histolytica Entamoeba histolytica 120.7 ug.mL-1
Inhibition of trypsin (unknown origin) using BApNA as substrate at 2 mg/ml incubated for 15 min prior to substrate addition measured after 30 min by UV/VIS spectrophotometric analysis Homo sapiens 75.2 %
Inhibition of AChE (unknown origin) Homo sapiens 12.0 nM
Inhibition of TRAP activity in RANKL-induced Balb/c mouse RAW264.7 cells at 10 uM after 1 hr by ELISA relative to control Mus musculus 71.68 %
Inhibition of TRAP activity in Balb/c mouse RAW264.7 cells at 10 uM after 1 hr by ELISA relative to control Mus musculus 145.67 %
Inhibition of TRAP activity in RANKL-induced Balb/c mouse RAW264.7 cells at 1 uM after 1 hr by ELISA relative to control Mus musculus 78.02 %
Inhibition of TRAP activity in Balb/c mouse RAW264.7 cells at 1 uM after 1 hr by ELISA relative to control Mus musculus 158.55 %
Inhibition of sEH (unknown origin) assessed as substrate PHOME hydrolysis at 25 uM after 1 hr by fluorescence method Homo sapiens 40.0 %
Inhibition of alpha-amylase (unknown origin) relative to control Homo sapiens 20.1 %
Inhibition of Mycobacterium tuberculosis MTCC 300 DAH7PS expressed in Escherichia coli BL21 (DE3) using 25 to 125 uM PEP/100 uM E4P as substrate at 10 uM by spectrophotometric analysis relative to control Mycobacterium tuberculosis 17.0 %
Antibacterial activity against Staphylococcus aureus MRSA ATCC 43300 (CO-ADD:GP_020); MIC in CAMBH media, using NBS plates, by OD(600) Staphylococcus aureus subsp. aureus 17.86 %
Antibacterial activity against Escherichia coli ATCC 25922 (CO-ADD:GN_001); MIC in CAMBH media using NBS plates, by OD(600) Escherichia coli 2.05 %
Antibacterial activity against Klebsiella pneumoniae MDR ATCC 70063 (CO-ADD:GN_003); MIC in CAMBH media using NBS plates, by OD(600) Klebsiella pneumoniae 10.13 %
Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 (CO-ADD:GN_042); MIC in CAMBH media using NBS plates, by OD(600) Pseudomonas aeruginosa 17.85 %
Antibacterial activity against Acinetobacter baumannii ATCC 19606 (CO-ADD:GN_034); MIC in CAMBH media using NBS plates, by OD600 Acinetobacter baumannii 25.94 %
Antifungal activity against Candida albicans ATCC 90028 (CO-ADD:FG_001); MIC in YNB media using NBS plates, by OD630 Candida albicans 3.37 %
Antifungal activity against Cryptococcus neoformans H99 ATCC 208821 (CO-ADD:FG_002); MIC in YNB media using NBS plates, by Resazurin OD(600-570) Cryptococcus neoformans -5.7 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of Caco-2 cells at 10 uM after 48 hours by high content imaging Homo sapiens 40.82 %
Inhibition of Enterobacter cloacae beta-lactamase at 500 uM incubated for 10 mins followed by nitrocefin substrate challenge and measured for 5 mins by spectrophotometric analysis relative to control Enterobacter cloacae 15.0 %
Anti-colitis activity in ICR mouse model of DSS-induced colitis assessed as inhibition of DSS-induced colorectum shortening at 6 mg, po for 14 days relative to control Mus musculus 73.0 %
Inhibition of F1F0-ATP synthase in Escherichia coli after 60 mins relative to control Escherichia coli 40.0 %
SARS-CoV-2 3CL-Pro protease inhibition percentage at 20µM by FRET kind of response from peptide substrate Severe acute respiratory syndrome coronavirus 2 12.75 %
Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.08 % Antiviral activity determined as inhibition of SARS-CoV-2 induced cytotoxicity of VERO-6 cells at 10 uM after 48 hours exposure to 0.01 MOI SARS CoV-2 virus by high content imaging Chlorocebus sabaeus -0.08 %
Inhibition of human liver FBP1 at 200 uM incubated for 5 mins by fluorescence method relative to control Homo sapiens 20.0 %
Inhibition of cytochrome c (unknown origin) assessed as reduction in cyt c-CL complex formation at 10 uM incubated for 15 mins in presence of cardiolipin by Trp-59 fluorescence assay relative to control Homo sapiens 66.0 %
Inhibition of cytochrome c (unknown origin) assessed as reduction in cyt c-CL peroxidase activity at 10 uM up to 20 mins in presence of cardiolipin by Amplex red staining based fluorescence assay relative to control Homo sapiens 28.0 %
Inhibition of cytochrome c (unknown origin) assessed as reduction reduction of cyt c from its ferric state to ferrous state at 10 uM incubated for 20 mins in presence of cardiolipin by UV-vis Spectrophotometric assay relative to control Homo sapiens 19.0 %

Related Entries

Cross References

Resources Reference
ChEBI 28527
ChEMBL CHEMBL226335
DrugBank DB01698
DrugCentral 3535
FDA SRS 5G06TVY3R7
Human Metabolome Database HMDB0003249
KEGG C05625
PDB RUT
PubChem 5280805
SureChEMBL SCHEMBL23243
ZINC ZINC000004096846